Now more than ever, blood glucose control is a major concern. During the COVID-19 pandemic, Hygieia continues to work with patients through their d-Nav Insulin Management program to reduce A1c and control blood glucose. Hygieia is unique, as it uses an FDA cleared mobile app to automate insulin titration based on each individual patient. Most commercial insurances, along with Medicare and Medicaid contract with the d-Nav program. Refer to the flyer below for more information on referring patients to improve A1c control and reduce COVID-19 complications.

Click here for the patient referral flyer.